NCT04982913

Single Dose and Multiple Dose Safety, Tolerability, PK，and Food Effect Study，and Interaction With Oseltamivir Study of HEC116094 in Healthy Adult Subjects

A Single-Center, Randomized, Double-Blind, Single and Multiple Doses, Placebo-Controlled Study,To Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics, Food Effects of HEC116094HCl•3H2O and the Interaction With Oseltamivir Phosphate Capsules in Chinese Healthy Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 118 (actual)
• Sponsor: Sunshine Lake Pharma Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The Safety, Tolerability, Pharmacokinetic, Food Effect Study and the interaction with Oseltamivir Phosphate Capsules of HEC116094 in Healthy Subjects

Conditions

• Influenza

Interventions

Type	Name	Description
DRUG	HEC116094	Part B：Mulltiple doses up to 5 days； Part C：Each cycle was administered for 5 days

Timeline

• Start date: 2021-08-24
• Primary completion: 2022-10-02
• Completion: 2022-10-02
• First posted: 2021-07-29
• Last updated: 2023-04-12

Locations

1 site across 1 country: China